The use of marginal grafts in liver transplantation

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 2, 2008, Pages 92-101

  Hashimoto, Koji ^a   Miller, Charles ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Extended criteria donors; Liver transplantation; Marginal grafts

Indexed keywords

DISEASE TRANSMISSION; DONOR SELECTION; FATALITY; FATTY LIVER; GRAFT FAILURE; HEART DEATH; HEPATITIS B; HEPATITIS C; HUMAN; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONOR; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PATIENT SELECTION; RECURRENT INFECTION; REVIEW; SAFETY; TREATMENT OUTCOME;

DONOR SELECTION; HUMANS; LIVER TRANSPLANTATION; TISSUE DONORS;

EID: 42049093804     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1300-z     Document Type: Review

References (100)

1. Pomfret EA, Fryer JP, Sima CS, Lake JR, Merion RM. Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1376-1389.
2. United Network for Organ Sharing website. Available at: http://www.unos.org, accessed September 2007.
3. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-663.
4. Barshes NR, Horwitz IB, Franzini L, Vierling JM, Goss JA. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007;7:1265-1270.
5. Greig PD, Forster J, Superina RA, Strasberg SM, Mohamed M, Blendis LM, et al. Donor-specific factors predict graft function following liver transplantation. Transplant Proc 1990;22:2072-2073.
6. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996;62:62-65.
7. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Pierangeli F, D'Errico A, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001;1:61-68.
8. Popper H. Aging and the liver. Prog Liver Dis 1986;8:659-683.
9. Serste T, Bourgeois N. Ageing and the liver. Acta Gastroenterol 2006;69:296-298.
10. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-505.
11. Russo MW, Galanko JA, Zacks SL, Beavers KL, Fried MW, Shrestha R. Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 2004;4:1133-1138.
12. Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007;84:331-339.
13. Ojo AO, Leichtman AB, Punch JD, Hanson JA, Dickinson DM, Wolfe RA, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000;36:153-159.
14. Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003;17:308-324.
15. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991;23:1536-1537.
16. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997;64:248-251.
17. Urena MA, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno Sanz C. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology 1999;46:1164-1173.
18. Imber CJ, St Peter SD, Handa A, Friend PJ. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002;8:415-423.
19. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20:829-838.
20. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003;10:447-456.
21. Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991;51:1000-1004.
22. Briceño J, Marchal T, Padillo J, Solórzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002;74:522-526.
23. Colonna JO 2nd, Shaked A, Gomes AS, Colquhoun SD, Jurim O, McDiarmid SV, et al. Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg 1992;216:344-350.
24. Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH, Charlton MR. Risk factors for and clinical course of nonanastomotic biliary strictures after liver transplantation. Am J Transplant 2003;3:885-890.
25. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998;28:638-645.
26. Pratschke J, Wilhelm MJ, Kusaka M, Basker M, Cooper DK, Hancock WW, Tilney NL. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999;67:343-348.
27. Weiss S, Kotsch K, Francuski M, Reutzel-Selke A, Mantouvalou L, Klemz R, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007;7:1584-1593.
28. Belzer FO, D'Alessandro AM, Hoffmann RM, Knechtle SJ, Reed A, Pirsch JD, et al. The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg 1992;215:579-583.
29. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-1584.
30. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001;7:51-58
31. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999;68:1058-1061.
32. Dodson SF. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors. Clin Transplant 2000;14:20-24.
33. Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transpl 2002;8:556-561.
34. Joya-Vazquez PP, Dodson FS, Dvorchik I, Gray E, Chesky A, Demetris AJ, et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002;73:1598-1602.
35. de Villa VH, Chen YS, Chen CL. Hepatitis B core antibodypositive grafts: recipient's risk. Transplantation 2003;75:S49-53.
36. Nery JR, Nery-Avila C, Reddy KR, Cirocco R, Weppler D, Levi DM, et al. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation 2003;75:1179-1186.
37. Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007;132:931-937.
38. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, et al. Outcomes of hepatitis C-and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl 2003;9:1053-1061.
39. Burton JR Jr, Shaw-Stiffel TA. Use of hepatitis B core antibodypositive donors in recipients without evidence of hepatitis B infection: A survey of current practice in the United States. Liver Transpl 2003;9:837-842.
40. Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001;7:762-768.
41. Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384-393.
42. Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 2006;12:1496-1503.
43. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995;59:197-203.
44. Otero A, Gomez-Gutierrez M, Suarez F, Arnal F, Fernandez-Garcia A, Aguirrezabalaga J, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 2003;76:1068-1073.
45. D'Alessandro AM, Hoffmann RM, Knechtle SJ, Odorico JS, Becker YT, Musat A, HW, et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000;128:579-588.
46. Reich DJ, Munoz SJ, Rothstein KD, Nathan HM, Edwards JM, Hasz RD, Manzarbeitia CY. Controlled non-heart-beating donor liver transplantation: A successful single center experience, with topic update. Transplantation 2000;70:1159-1166.
47. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: An increased incidence of biliary complications. Transplantation 2003;75:1659-1663.
48. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg 2005;242:724-731.
49. Muiesan P, Girlanda R, Jassem W, Melendez HV, O'Grady J, Bowles M, et al. Single-center experience with liver transplantation from controlled non-heartbeating donors: A viable source of grafts. Ann Surg 2005;242:732-738.
50. Fujita S, Mizuno S, Fujikawa T, Reed AI, Kim RD, Howard RJ, Hemming AW. Liver transplantation from donation after cardiac death: A single center experience. Transplantation 2007;84:46-49.
51. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004;239:87-92.
52. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006;244:555-562.
53. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: An analysis of OPTN/UNOS data. Am J Transplant 2006;6:791-796.
54. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006;82:1683-1688.
55. Doshi MD, Hunsicker LG. Short-and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007;7:122-129.
56. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: An organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007;84:272-274.
57. Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalmann U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996;9:426-429.
58. Frank S, Muller J, Bonk C, Haroske G, Schackert HK, Schackert G. Transmission of glioblastoma multiforme through liver transplantation. Lancet 1998;352:31.
59. Armanios MY, Grossman SA, Yang SC, White B, Perry A, Burger PC, Orens JB. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: Case study and review of the literature. Neuro Oncol 2004;6:259-263.
60. Penn I. The problem of cancer in organ transplant recipients: An overview. Transplant Sci 1994;4:23-32.
61. Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, et al. Donors with central nervous system malignancies: Are they truly safe? Transplantation 2003;76:340-343.
62. Serralta AS, Orbis FC, Sanjuan FR, Moya AH, López-Andújar R, Pareja EI, et al. If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy? Liver Transpl 2003;9:1281-1285
63. Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005;242:556-565.
64. Schiano TD, Kim-Schluger L, Gondolesi G, Miller CM. Adult living donor liver transplantation: The hepatologist's perspective. Hepatology 2001;33:3-9.
65. Miller CM, Gondolesi GE, Florman S, Matsumoto C, Munoz L, Yoshizumi T, et al. One hundred nine living donor liver transplants in adults and children: A single-center experience. Ann Surg 2001;234:301-312.
66. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, et al. Lessons learned from 1000 living donor liver transplantations in a single center: How to make living donations safe. Liver Transpl 2006;12:920-927.
67. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006;12:1485-1488.
68. Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Living-donor liver transplantation in the United States: Identifying donors at risk for perioperative complications. Am J Transplant 2007;7:2344-2349.
69. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL Consortium. Ann Surg 2005;242:314-323.
70. Foster R, Zimmerman M, Trotter JF. Expanding donor options: Marginal, living, and split donors. Clin Liver Dis 2007;11:417-429.
71. Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004;40:699-707.
72. Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004;10:1248-1255.
73. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, et al. Living donor liver transplantation for hepatitis C-related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 2006;12:560-565.
74. Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: A singlecenter study of 289 patients. Liver Transpl 2007;13:687-692.
75. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, et al.; A2ALL Study Group. Outcomes in hepatitis C virusinfected recipients of living donor vs deceased donor liver transplantation. Liver Transpl 2007;13:122-129.
76. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al.; A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007;7:1601-1608.
77. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135:336-340.
78. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, et al. Feasibility of left lobe living donor liver transplantation between adults: An 8-year, single-center experience of 107 cases. Am J Transplant 2006;6:1004-1011.
79. Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Fujimoto Y, Ogawa K. Small-for-size graft in living donor liver transplantation: How far should we go? Liver Transpl 2003;9:S29-35.
80. Merion RM, Rush SH, Dykstra DM, Goodrich N, Freeman RB Jr, Wolfe RA. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 2004;4:1792-1797.
81. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al.; European Liver Transplant Association. 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet 2006;367:225-232.
82. Rogiers X, Malago M, Habib N, Knoefel WT, Pothmann W, Burdelski M, et al. In situ splitting of the liver in the heartbeating cadaveric organ donor for transplantation in two recipients. Transplantation 1995;59:1081-1083.
83. Rogiers X, Malago M, Gawad K, Jauch KW, Olausson M, Knoefel WT, et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996;224:331-339.
84. Goss JA, Yersiz H, Shackleton CR, Seu P, Smith CV, Markowitz JS, et al. In situ splitting of the cadaveric liver for transplantation. Transplantation 1997;64:871-877.
85. Ramcharan T, Glessing B, Lake JR, Payne WD, Humar A. Outcome of other organs recovered during in situ split-liver procurements. Liver Transpl 2001;7:853-857.
86. Yersiz H, Renz JF, Hisatake G, Reichert PR, Feduska NJ Jr, Lerner S, et al. Technical and logistical considerations of in situ split-liver transplantation for two adults: Part I. Creation of left segment II, III, IV and right segment I, V-VIII grafts. Liver Transpl 2001;7:1077-1080.
87. Deshpande RR, Bowles MJ, Vilca-Melendez H, Srinivasan P, Girlanda R, Dhawan A, et al. Results of split liver transplantation in children. Ann Surg 2002;236:248-253.
88. Broering DC, Kim JS, Mueller T, Fischer L, Ganschow R, Bicak T, et al. One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: Lessons learned and outlook for the future. Ann Surg 2004;240:1002-1012.
89. Kim JS, Groteluschen R, Mueller T, Ganschow R, Bicak T, Wilms C, et al. Pediatric transplantation: The Hamburg experience. Transplantation 2005;79:1206-1209.
90. D'Alessandro AM, Knechtle SJ, Chin LT, Fernandez LA, Yagci G, Leverson G, Kalayoglu M. Liver transplantation in pediatric patients: 20 years of experience at the University of Wisconsin. Pediatr Transplant 2007;11:661-670.
91. Rela M, Vougas V, Muiesan P, Vilca-Melendez H, Smyrniotis V, Gibbs P, et al. Split liver transplantation: King's College Hospital experience. Ann Surg 1998;227:282-288.
92. Emond JC, Freeman RB Jr, Renz JF, Yersiz H, Rogiers X, Busuttil RW. Optimizing the use of donated cadaver livers: Analysis and policy development to increase the application of split-liver transplantation. Liver Transpl 2002;8:863-872.
93. Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW. One hundred in situ split-liver transplantations: A single-center experience. Ann Surg 2003;238:496-505.
94. Washburn K, Halff G, Mieles L, Goldstein R, Goss JA. Split-liver transplantation: Results of statewide usage of the right trisegmental graft. Am J Transplant 2005;5:1652-1659.
95. Wilms C, Walter J, Kaptein M, Mueller L, Lenk C, Sterneck M, et al. Long-term outcome of split liver transplantation using right extended grafts in adulthood: A matched pair analysis. Ann Surg 2006;244:865-872.
96. Humar A, Ramcharan T, Sielaff TD, Kandaswamy R, Gruessner RW, Lake JR, Payne WD. Split liver transplantation for two adult recipients: An initial experience. Am J Transplant 2001;1:366-372.
97. Andorno E, Genzone A, Morelli N, Mondello R, Colledan M, Gridelli B, et al. One liver for two adults: In situ split liver transplantation for two adult recipients. Transplant Proc 2001;33:1420-1422.
98. Azoulay D, Castaing D, Adam R, Savier E, Delvart V, Karam V, et al. Split-liver transplantation for two adult recipients: Feasibility and long-term outcomes. Ann Surg 2001;233:565-574.
99. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Splitliver transplantation in the United States: Outcomes of a national survey. Ann Surg 2004;239:172-181.
100. Cardillo M, De Fazio N, Pedotti P, De Feo T, Fassati LR, Mazzaferro V, et al. NITp Liver Transplantation Working Group. Split and whole liver transplantation outcomes: A comparative cohort study. Liver Transpl 2006;12:402-410.